Colace and Metastasis - a phase IV clinical study of FDA data

Summary:

Metastasis is reported as a side effect among people who take Colace (docusate ), especially for people who are female, 60+ old, also take Zometa, and have Bone loss.

The phase IV clinical study analyzes which people have Metastasis when taking Colace. It is created by eHealthMe based on reports of 41,100 people who have side effects when taking Colace from the FDA, and is updated regularly.

What is Colace?

Colace has active ingredients of docusate . It is often used in constipation. eHealthMe is studying from 41,841 Colace users. Check the latest studies of Colace.

What is Metastasis?

Metastasis (spreadable cancer to other organ from origin) is found to be associated with 537 drugs and 841 conditions by eHealthMe. Check the latest studies of Metastasis.

On Aug, 01, 2026

41,100 people reported to have side effects when taking Colace.
Among them, 34 people (0.08%) have Metastasis.

Among these 34 people:

What is the gender of people who have Metastasis when taking Colace? *

female: 56.25 %
male: 43.75 %

What is the age of people who have Metastasis when taking Colace? *

What are other drugs people take besides Colace? *

Zometa: 15 people, 44.12%
Levaquin: 12 people, 35.29%
Allopurinol: 11 people, 32.35%
Ibuprofen: 11 people, 32.35%
Protonix: 11 people, 32.35%
Valium: 11 people, 32.35%
Flagyl: 10 people, 29.41%
Pepcid: 10 people, 29.41%
Cipro: 10 people, 29.41%
Phenazopyridine Hcl Tab: 9 people, 26.47%

What are other side effects people have besides Metastasis? *

Pain: 16 people, 47.06%
Death: 15 people, 44.12%
Anaemia (lack of blood): 15 people, 44.12%
Fatigue (feeling of tiredness): 14 people, 41.18%
Nausea (feeling of having an urge to vomit): 13 people, 38.24%
Dyspnea (difficult or laboured breathing): 12 people, 35.29%
Bone Disorder: 12 people, 35.29%
Unilateral Hydronephrosis (kidney stone that causes obstruction of the ureter): 11 people, 32.35%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 11 people, 32.35%
Pneumonia: 11 people, 32.35%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 9 people, 26.47%
Bone Loss: 9 people, 26.47%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 4 people, 11.76%
Renal Cell Carcinoma (a kidney cancer): 3 people, 8.82%
Renal Cell Carcinoma Stage Iv (stage iv renal cell cancer have cancer that has spread to other organs, such as the lungs, liver, bones, or brain, and may have spread to lymph nodes): 2 people, 5.88%
Breast Cancer: 2 people, 5.88%
Heart Disease: 2 people, 5.88%
Pain: 2 people, 5.88%
Leiomyosarcoma (a very rare soft tissue sarcoma (cancer) that grows in muscle tissue): 1 person, 2.94%
Colon Cancer: 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Colace and have Metastasis?

- Check whether Metastasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Colace:

Colace (41,841 reports)

Metastasis treatments and more:

Metastasis (11,222 reports)

Browse all side effects of Colace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Metastasis:

Metastasis (537 drugs)

Browse all the conditions that are associated with Metastasis:

Metastasis (841 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on docusate (the active ingredients of Colace) and Colace (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.